Free genetic testing, offered partially or fully subsidized by industry, may have trade-offs, and health systems in Canada must carefully weigh potential clinical, ethical, and legal considerations to protect patient data, authors argue in a CMAJ (Canadian Medical Association Journal) commentary https://www.cmaj.ca/lookup/doi/10.1503/cmaj.231588.
Key Republicans nix idea to give FDA new power to regulate CBD
WASHINGTON – The Food and Drug Administration says it needs Congress to give it more power to regulate CBD. Two powerful congressional Republicans made clear
July 27, 2023